Jordan Scopa

Partner

Goodmans

Office Phone:

(416) 979-2211

Direct Phone:

(416) 849-6914


  Pro - Try 1 Week Free
 

    and access,

  •     79K PE/M&A Contacts
  •     +
  •     4.6K PE Firms
  •     3.6K M&A Advisors
  •     198K Transactions
  •     201K Companies

  •     Market Services
  •     Build Lists
  •     Research Sectors
  •     Uncover Opportunities

Bio

Jordan Scopa is a partner in the Litigation Group at Goodmans. He practises commercial litigation, with an emphasis on intellectual property disputes, including disputes relating to patents, trademarks and copyright. He also advises clients regarding the licensing of intellectual property and technology. Jordan also advises pharmaceutical clients regarding pricing strategy and regulatory issues, including those relating to the Patented Medicines Prices Review Board (“PMPRB”). Jordan has been counsel on a number of significant cases involving patent validity and infringement. He has also acted on the leading cases involving the assessment and quantification of damages, both for patent infringement and pursuant to section 8 of the Patented Medicines (NOC) Regulations. He appears regularly before the Federal Court and the Federal Court of Appeal. Jordan is recognized by numerous publications for his IP expertise including Chambers Global and Chambers Canada where he is described as a “future leader”, a “rising star”, a “highly skilled lawyer” and as having “experience beyond his years” in “high-profile” cases. The Canadian Legal Lexpert Directory recognizes Jordan as consistently recommended in Intellectual Property Litigation, while WTR 1000 note "Jordan is an elite litigator and a superb client manager. He is the total package: a brilliant and original thinker, adaptable and collaborative, and he has an outstanding business sense.” Who’s Who Legal Life Sciences: Patent Litigation and Who’s Who Legal Canada – Life Sciences also note Jordan is a “great lawyer” with “superb knowledge of the pharmaceutical sector” and a national and global leader in patent litigation. In 2021 and 2022, Jordan was featured in the Lexpert Special Edition: Technology and Health Sciences, and the 2022 Lexpert Special Edition: Litigation leading lawyers. He continues to be recognized by Best Lawyers in Canada, The Legal 500 Canada, WTR 1000, IAM Patent 1000, where he is described as “extremely effective, with a great command of procedural and substantive law.”

Education